We are very happy to announce that our manuscript on the mutational footprints of cancer therapies has been published in December’s issue of Nature Genetics.
In this manuscript, we identify the mutational signatures of six anticancer therapies across more than 3500 metastatic tumors. Exploiting these footprints, we estimate the contribution of different treatments to the mutation burden of metastatic tumors. This study opens a window to a more precise understanding of the long term side-effects of cancer therapies.

Link to the paper

See Núria López-Bigas thread on Tweeter

See also Behind the Paper by Abel González-Pérez